Skip to main content
Fig. 5 | BMC Medicine

Fig. 5

From: The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01E vaccination and seasonal malaria chemoprevention versus either intervention given alone

Fig. 5

Timing of microscopically confirmed clinical malaria episodes after the final SMC cycle in each year of the study, among recipients of RTS,S/AS01E, randomised to receive either placebo SMC (RTS,S alone group) or active SMC (Combined group). Points show the timing of episodes of the primary outcome in the RTS,S/AS01E alone group (who received placebo SMC and the RTS,S vaccine) and the Combined group (who received active SMC and the RTS,S vaccine), in relation to the final SMC cycle administered each year (SMC 4 in year 1, SMC 8 in year 2, and SMC 12 in year 3). The position relative to the y-axis indicates the age in months of the child at the time of the episode

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us